Tula System
Tusker Medical, Inc. · Decision date Oct 24, 2025
What did the FDA decide?
FDA records P190016/S010 as a supplement to PMA P190016, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 24, 2025.
FDA approval order statement
approval for removal of lot release testing for Tula Tube Delivery System (TDS)
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ear, Nose, Throat
- Decision date
- Oct 24, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P190016/S010
- Regulatory pathway
- PMA supplement
- Applicant
- Tusker Medical, Inc.
- Product code
- QJA
- Decision code
- OK30
- Decision date
- Oct 24, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tympanostomy tube delivery product with drug.
- Applicant
- Tusker Medical, Inc.
- Product code
- QJA
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P190016/S010 received
Application receipt date recorded by FDA.
P190016/S010 · FDA decision
30-Day Notice
P190016/S011 · Related supplement
Tula Tube Delivery System (TDS)
P190016/S012 · Related supplement
Tula System
Timeline entries are records held by MedtechLedger for P190016. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P190016
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Tula Tube Delivery System (TDS)P190016/S011 | Tusker Medical, Inc. | PMA supplement | Jan 21, 2026 | FDA |
Tula SystemP190016/S012 | Tusker Medical, Inc. | PMA supplement | Jul 31, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Tusker Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 155 Jefferson Dr., Suite 200, Menlo Park, CA, 94025
Sources and methodology
- Original FDA record: P190016/S010
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
